November 01, 2025
The simulators market size is projected to expand from USD 14.72 billion in 2026 to USD 25.53 billion by 2034,...
Read MoreNovember 26, 2025
The U.S. behavioral health market is anticipated to grow from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 01, 2025
The anti-aging market size is expected to rise from USD 84.4 billion in 2026 to USD 129.88 billion by 2034, gr...
Read MoreNovember 01, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreNovember 01, 2025
The global cell culture media market, valued at USD 6.9 billion in 2024, is anticipated to reach USD 20.32 billion by 2034, growing at a CAGR of 11.45% over the next decade. In 2024, North America led the global cell culture media market, while Asia-Pacific is set for the fastest growth. Liquid media and serum-free media held the largest shares. Bi...
November 01, 2025
According to market projections, the clinical trial biorepository and archiving solutions sector is expected to grow from USD 4.4 billion in 2024 to USD 9.69 billion by 2034, reflecting a CAGR of 8.21%. In 2024, North America led the clinical trial biorepository and archiving solutions market with a 49% share, while Asia Pacific is set for the fast...
November 01, 2025
Based on market forecasts, the cell and gene therapy CDMO sector will expand from USD 6.41 billion in 2024 to USD 75.32 billion by 2034, experiencing a CAGR of 27.94%. In 2024, North America led the cell and gene therapy CDMO market with a 41% share, while Asia Pacific is set for the fastest growth. Oncology dominated by indication, but rare diseas...
November 01, 2025
The diabetic retinopathy industry is projected to rise from USD 9.52 billion in 2024 to USD 17.82 billion by 2034, reflecting a CAGR of 6.47% over the next decade. In 2024, North America led the diabetic retinopathy market, while Asia-Pacific is set for strong growth. Non-proliferative diabetic retinopathy held the largest share, but proliferative ...
November 01, 2025
According to market projections, the topical drugs CDMO sector is expected to grow from USD 46.32 billion in 2024 to USD 136.71 billion by 2034, reflecting a CAGR of 11.43%. In 2024, Asia Pacific led the topical drugs CDMO market, with Latin America poised for strong growth. Semi-solid formulations and contract manufacturing dominated, while liquid...
November 01, 2025
Forecasts suggest that the small molecule CDMO market will expand from USD 72.81 billion in 2024 to USD 145.12 billion by 2034, with a CAGR of 7.14% during this period. In 2024, North America led the small molecule CDMO market, with APIs holding the largest product share and innovators dominating by drug type. Oncology was the top application. Look...
November 01, 2025
Based on market forecasts, the oligonucleotide CDMO sector will expand from USD 2.55 billion in 2024 to USD 18.37 billion by 2034, experiencing a CAGR of 21.83%. In 2024, North America led the oligonucleotide CDMO market, with Asia Pacific poised for the fastest growth. Contract manufacturing dominated by service, while contract development is set ...
November 01, 2025
According to forecasts, the global active pharmaceutical ingredients CDMO market will grow from USD 127.45 billion in 2024 to USD 260.98 billion by 2034, with an expected CAGR of 7.43%. In 2024, Asia-Pacific led the global API market, while North America is set for strong CDMO growth. Traditional APIs and synthetic synthesis dominated, but antibody...
November 01, 2025
Based on market forecasts, the medical waste management sector will expand from USD 36.84 billion in 2024 to USD 79.83 billion by 2034, experiencing a CAGR of 8.04%. In 2024, North America led the medical waste management market, while Asia Pacific is set for the fastest growth. Offsite treatment dominated, but on-site methods are gaining traction....
November 01, 2025
According to forecasts, the global fertility market will grow from USD 36.57 billion in 2024 to USD 87.05 billion by 2034, with an expected CAGR of 9.06%. In 2024, Europe led the global fertility market share by 34%, while Asia-Pacific is set for the fastest growth ahead. Assisted reproductive technology dominated by offerings, while fertility drug...